| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Aug 24 | CERE Cerevel Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 10,666 | 0.00 | 0 |
| 1 Aug 24 | CERE Cerevel Therapeutics | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 59,171 | 0.00 | 0 |
| 1 Aug 24 | CERE Cerevel Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0 | 614,428 | 0.00 | 0 |
| 29 May 24 | SPRO Spero Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 20,000 | 0.00 | 55,000 |
| 19 Jan 24 | CERE Cerevel Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 59,171 | 0.00 | 59,171 |
| 2 Jan 24 | SPRO Spero Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.12 | 35,604 | 39.88 k | 35,604 |
| 26 Dec 23 | CERE Cerevel Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 10.05 | 3,150 | 31.66 k | 10,666 |
| 26 Dec 23 | CERE Cerevel Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | No | 10.05 | 3,150 | 31.66 k | 255,082 |
